Grassley says FDA was aware of Avandia danger

05/25/2007 | Washington Post (tiered subscription model), The

Sen. Charles Grassley, R-Iowa, said the FDA's own preliminary evaluation indicated significant heart risk from the GlaxoSmithKline diabetes drug Avandia. Grassley also noted FDA safety watchdogs urged a black-box warning for the drug several months ago, and he criticized the FDA for wanting to wait up to two years for data from a new clinical trial.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC